The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Open accessAbstract
Systemic autoimmune disease in humans and mice is characterized by loss of immunologic tolerance to a restricted set of self-nuclear antigens. Autoantigens, such as double-stranded (ds) DNA and the RNA-containing Smith antigen (Sm), may be selectively targeted in systemic lupus erythematosus because of their ability to activate a putative common receptor. Toll-like receptor 9 (TLR9), a receptor for CpG DNA, has been implicated in the activation of autoreactive B cells in vitro, but its role in promoting autoantibody production and disease in vivo has not been determined. We show that in TLR9-deficient lupus-prone mice, the generation of anti-dsDNA and antichromatin autoantibodies is specifically inhibited. Other autoantibodies, such as anti-Sm, are maintained and even increased in TLR9-deficient mice. In contrast, ablation of TLR3, a receptor for dsRNA, did not inhibit the formation of autoantibodies to either RNA- or DNA-containing antigens. Surprisingly, we found that despite the lack of anti-dsDNA autoantibodies in TLR9-deficient mice, there was no effect on the development of clinical autoimmune disease or nephritis. These results demonstrate a specific requirement for TLR9 in autoantibody formation in vivo and indicate a critical role for innate immune activation in autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 2×
“TLR9, a receptor for hypomethylated CpG DNA motifs (9), is expressed by B cells in humans (10) and mice (9) and has been implicated in the breakdown of immunologic tolerance to self-nucleic acids in SLE.”
BackgroundSelf-citationTakeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Self-citationRecognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Self-citationInnate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,235
Self-citationDevelopment of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Self-citationCasciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E., Nilsen, N. J., Espevik, T., & Golenbock, D. T. (2004) · Nature Immunology · doi:10.1038/ni1028 · Cited by 1,361
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
Maziad, A. S. A., Torrealba, J., Seikaly, M. G., Hassler, J. R., & Hendricks, A. R. (2017) · Case Reports in Nephrology and Dialysis · doi:10.1159/000475493 · Cited by 1,299
Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
Lund, J., Sato, A., Akira, S., Medzhitov, R., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030162 · Cited by 1,198
Self-citationlpr And gld: Single Gene Models Of Systemic Autoimmunity And Lymphoproliferative Disease
Cohen, P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.243 · Cited by 1,196
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062
Muzio, M., Bosisio, D., Polentarutti, N., D’amico, G., Stoppacciaro, A., Mancinelli, R., van’t Veer, C., Penton-Rol, G., Ruco, L. P., Allavena, P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5998 · Cited by 1,060
Chan, O. T. M., Hannum, L. G., Haberman, A. M., Madaio, M. P., & Shlomchik, M. J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1639 · Cited by 698
Self-citationSpliceosomal UsnRNP biogenesis, structure and function
Will, C. L., & Lührmann, R. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00211-8 · Cited by 696
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 682
Bernasconi, N. L., Onai, N., & Lanzavecchia, A. (2003) · Blood · doi:10.1182/blood-2002-11-3569 · Cited by 667
Kotzin, B. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81108-3 · Cited by 660
Cohen, P. L., Caricchio, R., Abraham, V., Camenisch, T. D., Jennette, J. C., Roubey, R. A. S., Earp, H. S., Matsushima, G., & Reap, E. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012094 · Cited by 636
Viral infection switches non-plasmacytoid dendritic cells into high interferon producers
Diebold, S. S., Montoya, M., Unger, H., Alexopoulou, L., Roy, P., Haswell, L. E., Al-Shamkhani, A., Flavell, R., Borrow, P., & Sousa, C. R. E. (2003) · Nature · doi:10.1038/nature01783 · Cited by 582
Self-citationFrom T to B and back again: positive feedback in systemic autoimmune disease
Shlomchik, M. J., Craft, J. E., & Mamula, M. J. (2001) · Nature Reviews Immunology · doi:10.1038/35100573 · Cited by 572
Self-citationAarden, L. A., Groot, E. R. D., & Feltkamp, T. E. W. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29197.x · Cited by 563 · cited 1×
“Indirect immunofluorescence on Crithidia luciliae substrates is an established assay for the detection of antidsDNA autoantibodies in SLE (24).”
BackgroundThe Role of Complement in the Development of Systemic Lupus Erythematosus
Manderson, A. P., Botto, M., & Walport, M. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104549 · Cited by 538
Activation of Autoreactive B Cells by CpG dsDNA
Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J., & Marshak-Rothstein, A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00323-6 · Cited by 521
Self-citationBoulé, M. W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 518
Self-citationType-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice
Santiago-Raber, M.-L., Baccala, R., Haraldsson, K. M., Choubey, D., Stewart, T. A., Kono, D. H., & Theofilopoulos, A. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021996 · Cited by 509
Hoebe, K., Janssen, E. M., Kim, S. O., Alexopoulou, L., Flavell, R. A., Han, J., & Beutler, B. (2003) · Nature Immunology · doi:10.1038/ni1010 · Cited by 446
Self-citationKavanaugh, A., Tomar, R., Reveille, J., Solomon, D. H., & Homburger, H. A. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0071-gfcuot · Cited by 443
Induction of various autoantibodies by mutant gene lpr in several strains of mice.
Izui, S., Kelley, V. E., Masuda, K., Yoshida, H., Roths, J. B., & Murphy, E. D. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.1.227 · Cited by 386
Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM
Boes, M., Schmidt, T., Linkemann, K., Beaudette, B. C., Marshak-Rothstein, A., & Chen, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1184 · Cited by 370
Pettersson, I., Hinterberger, M., Mimori, T., Gottlieb, E., & Steitz, J. A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91101-4 · Cited by 366
Profiles of Antinuclear Antibodies in Systemic Rheumatic Diseases
Notman, D. D., KURATA, N., & TAN, E. M. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-4-464 · Cited by 365
The role of B cells in lpr/lpr-induced autoimmunity.
Shlomchik, M. J., Madaio, M. P., Ni, D., Trounstein, M., & Huszar, D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1295 · Cited by 361
Self-citationLethal anemia caused by interferon-β produced in mouse embryos carrying undigested DNA
Yoshida, H., Okabe, Y., Kawane, K., Fukuyama, H., & Nagata, S. (2005) · Nature Immunology · doi:10.1038/ni1146 · Cited by 359
The use of laboratory tests in the diagnosis of SLE
Egner, W. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.6.424 · Cited by 316
A FADD-dependent innate immune mechanism in mammalian cells
Balachandran, S., Thomas, E., & Barber, G. N. (2004) · Nature · doi:10.1038/nature03124 · Cited by 293
Genomic DNA Released by Dying Cells Induces the Maturation of APCs
Ishii, K. J., Suzuki, K., Coban, C., Takeshita, F., Itoh, Y., Matoba, H., Kohn, L. D., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2602 · Cited by 237
Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites
Vlahakos, D. V., Foster, M. H., Adams, S., Katz, M., Ucci, A. A., Barrett, K. J., Datta, S. K., & Madaio, M. P. (1992) · Kidney International · doi:10.1038/ki.1992.242 · Cited by 216
Alba, P., Bento, L., Cuadrado, M. J., Karim, Y., Tungekar, M. F., Abbs, I., Khamashta, M. A., D'Cruz, D., & Hughes, G. R. V. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.6.556 · Cited by 213
Amoura, Z., Chabre, H., Koutouzov, S., Lotton, C., Cabrespines, A., Bach, J., & Jacob, L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371118 · Cited by 208
Type I IFN Protects Against Murine Lupus
Hron, J. D., & Peng, S. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2134 · Cited by 201
The autoantibody repertoire: searching for order
Plotz, P. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri976 · Cited by 187
Editors and Editing of Anti-DNA Receptors
Li, H., Jiang, Y., Prak, E. T. L., Radic, M. Z., & WEIGERT, M. G. (2001) · Immunity · doi:10.1016/s1074-7613(01)00251-5 · Cited by 182
Sato, S. (2002) · International Immunology · doi:10.1093/intimm/dxf046 · Cited by 167
Waters, S. T., McDuffie, M., Bagavant, H., Deshmukh, U. S., Gaskin, F., Jiang, C., Tung, K. S. K., & Fu, S. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031519 · Cited by 160
Emlen, W., & O'Neill, L. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400910 · Cited by 139
Measurement of anti-DNA antibodies: a reappraisal using five different methods.
Isenberg, D. A., Dudeney, C., Williams, W., Addison, I. E., Charles, S., Clarke, J., & Todd-Pokropek, A. E. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.6.448 · Cited by 110
Cocca, B. A., Seal, S. N., D’Agnillo, P., Mueller, Y. M., Katsikis, P. D., Rauch, J., WEIGERT, M. G., & Radic, M. Z. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241510698 · Cited by 103
Mukae, N., Yokoyama, H., Yokokura, T., Sakoyama, Y., & Nagata, S. (2002) · Genes & Development · doi:10.1101/gad.1022802 · Cited by 97
Ma, J., Xu, J., Madaio, M. P., Peng, Q., Zhang, J., Grewal, I. S., Flavell, R. A., & Craft, J. E. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.417 · Cited by 91
Self-citationGoeckeritz, B. E., Flora, M. N., Witherspoon, K., Vos, Q., Lees, A., Dennis, G. J., Pisetsky, D. S., Klinman, D. M., Snapper, C. M., & Mond, J. J. (1999) · International Immunology · doi:10.1093/intimm/11.10.1693 · Cited by 53
Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation
Wang, Y. (2003) · International Immunology · doi:10.1093/intimm/dxg020 · Cited by 48
Lian, Z., Kikuchi, K., Yang, G., Ansari, A. A., Ikehara, S., & Gershwin, M. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5283 · Cited by 43
Directing Autoimmunity to Nucleoprotein Particles
Hardin, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030130 · Cited by 39
Marshak‐Rothstein, A., Busconi, L., Lau, C. M., Tabor, A. S., Leadbetter, E. A., Akira, S., Krieg, A. Μ., Lipford, G. B., Viglianti, G. A., & Rifkin, I. R. (2004) · Journal of Endotoxin Research · doi:10.1179/096805104225005850 · Cited by 38
Self-citation
Cited by
Toll-like Receptors and the Control of Immunity
Fitzgerald, K. A., & Kagan, J. C. (2020) · Cell · doi:10.1016/j.cell.2020.02.041 · Cited by 2,168
Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S., Chamilos, G., Sebasigari, R., Riccieri, V., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001180 · Cited by 1,303
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
New insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Metadata
- Authors
- Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-07-18
- Volume
- 202
- Issue
- 2
- Pages
- 321-331
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2166626628
- Cited by
- 516
- References
- 63
- FWCI
- 26.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.